To evaluate effect of Tiladi Kwatha Orally & Shatpushpa Siddha Taila Nasya in the treatment of Pushpaghni (PCOS)

Phase 2/3

Not yet recruiting

• Conditions: Polycystic ovarian syndrome. Ayurveda Condition: ARTAVADOSHAH/ARTAVADUSHTIH/RAJODOSHAH,

• Registration Number: CTRI/2023/08/055952
• Lead Sponsor: Post Graduate Institute of Ayurved, Jodhpur Rajasthan

Brief Summary

This is single group clinical study, open label to evaluate the effect of nasya with shatpushpa taila and tiladi kwatha in the management of Pushpughni (PCOS). The primary outcome of this treatment to reduce menstrual abnormality (Oligomenorrhea) ,  hypomenorrhea,  Menorrhagia, Pain associated with Menstruation ,Assessment of Acne (according to acne grading) , Hirsutism (on the basis of site).

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-07-26
• Study Start: 2023-08-15

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

• 1.Patients diagnosed cases of PCOS by the Rotterdam criteria.
• 2.Age: Patients aged between 16-40 years.
• The patients who are fit for the Nasya procedure were only considered for the study.

Exclusion Criteria

• •Patients having any other disease causing oligomenorrhea and anovulation excluding PCOD on the above criteria.
• •Patients using oral contraceptive pills.
• •Pregnant and lactating women.
• •Patients suffering from thyroid abnormalities, Hyperprolactinemia, adrenal hyperplasia etc.
• •Patients with any organic reproductive system abnormalities like hydrosalpinx, endometriosis, fibroid uterus, carcinoma of reproductive organ and sexually transmitted disease (STDs), Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antigen (HBsAg).
• •Systemic disorders like-uncontrolled diabetes mellitus, chronic liver disease, renal disorder, Uncontrolled hypertension, Diagnosed case of any type of malignancy.
• •Patients who are contraindicated for Nasya like, Nasal polyp etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
2.Assessment for Hypomenorrhea	for 8 weeks
1.Assessment for Menstrual abnormality (Oligomenorrhea)	for 8 weeks
4.Pain associated with Menstruation	for 8 weeks
3.Assessment for Menorrhagia	for 8 weeks
5.Assessment of Acne (according to acne grading)	for 8 weeks
6.Assessment of Hirsutism (on the basis of site)	for 8 weeks

Secondary Outcome Measures

Name	Time	Method
•Percentage improvement in reduction of ovarian size, volume, stromal pattern	•Percentage improvement in biochemical values.

Trial Locations

Locations (1)

Post Graduate Institute of Ayurved Jodhpur; 🇮🇳 Jodhpur, RAJASTHAN, India

Post Graduate Institute of Ayurved Jodhpur

🇮🇳Jodhpur, RAJASTHAN, India

Dr Sanoor Bano

Principal investigator

9672256870

sanurbano721@gmail.com